Granite FO LLC
VRTX icon

Granite FO LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Granite FO LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.18K Hold
8
– – ﹤0.01% 116
2026
Q2 		$3.97K Hold
8
– – ﹤0.01% 112
2026
Q1 		$3.57K Hold
8
– – ﹤0.01% 115
2025
Q4 		$3.63K Hold
8
– – ﹤0.01% 123
2025
Q3 		$3.13K Hold
8
– – ﹤0.01% 143
2025
Q2 		$3.56K Hold
8
– – ﹤0.01% 131
2025
Q1 		$3.88K Hold
8
– – ﹤0.01% 127
2024
Q4 		$3.22K Hold
8
– – ﹤0.01% 132
2024
Q3 		$3.72K Buy
+8
New +$3.84K ﹤0.01% 128
2024
Q2 		– Sell
-8
Closed -$3.92K – 183
2024
Q1 		$3.92K Buy
+8
New +$3.38K ﹤0.01% 138

Other funds holding VRTX

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Granite FO LLC's VRTX Position: Q3 2026 in Review

Granite FO LLC held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 8 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #116.

Granite FO LLC first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 906 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Granite FO LLC held 8 shares of Vertex Pharmaceuticals worth $4.18K as of Q3 2026.
  • Granite FO LLC left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Granite FO LLC's portfolio in Q3 2026, its #116 holding.
  • Granite FO LLC first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 906 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Granite FO LLC's 13F filing for Q3 2026, filed 14 Oct 2026.